Of late, the vaccines market is burgeoning with immense activities. Big pharmaceutical companies like GSK, Pfizer, Merck etc. are struggling to maintain their revenue and operating incomes amidst patent cliffs of blockbuster drugs. In such a scenario, vaccines, which have high entry barriers for generic players and the potential to generate blockbuster sales, are increasingly alluring the players.
Besides, the market has also gained momentum due to the recent technological advances that now allow the manufacturing of high efficacy combination vaccines, providing protection from a plethora of diseases in one schedule. This has resulted in the introduction of several promising vaccines, actively promoted by health agencies and non-profit organizations to offer maximum immunization coverage, especially in the developing regions with high incidence rates of infectious diseases.
The report, "Global Vaccine Market Forecast to 2017" provides an extensive research and in-depth analysis of the current status and future outlook of the global vaccine market. The market, which stood at US$ 27.3 bllion in 2012, is expected to grow at a CAGR of around 12% during 2012-2017.
In the report, the vaccine market has been studied on three distinct levels: Regional, Therapeutic Category, and Company. For regional analysis, key vaccine markets that together constitute around 90% of the global market, have been profiled. Further, the market has been broken down into 16 distinct therapeutic categories and their current and future outlook to 2017 has been analyzed. Through this, our analysts have conducted a thorough opportunity assessment in various therapeutic categories and regions to clearly highlight avenues which offer maximum opportunities for growth.
The study further delves into the business dynamics of the major players in industry. To provide a thorough understanding of a company's business model, the company's current and historical financials have been analyzed. Moreover, our team has also analyzed each company's strengths and weaknesses along with its vaccine portfolio and pipeline that will help the reader to better position his company vis-à-vis competition. This will help the reader to gain a deeper insight into each key market player.
Browse more Vaccines Market Research Reports